ArticleClinicoEconomics and outcomes research : CEOR2024

Resources Utilization Assessment and Cost-Minimization Analysis of the 6-Monthly Formulation of Triptorelin in the Treatment of Prostate Cancer in China.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.